Emmaus Life Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' DEFICIT (Details 3)	Dec. 31, 2020 $ / shares shares	Jun. 29, 2020 $ / shares	Jun. 19, 2019 $ / shares	Oct. 31, 2018 $ / shares shares
Class Of Warrant Or Right [Line Items]
Stock price \| $ / shares		$ 1.67	$ 10.30
Number outstanding \| shares	8,439,480
Convertible Promissory Note [Member]
Class Of Warrant Or Right [Line Items]
Stock price \| $ / shares	$ 1.68			$ 1.23
Number outstanding \| shares	1,250,000			1,250,000
Convertible Promissory Note [Member] \| Measurement Input, Exercise Price [Member]
Class Of Warrant Or Right [Line Items]
Warrants and rights outstanding, measurement input	2.05			2.05
Convertible Promissory Note [Member] \| Risk-free Interest Rate (South Korea government bond) [Member]
Class Of Warrant Or Right [Line Items]
Warrants and rights outstanding, measurement input	0.31			0.33
Convertible Promissory Note [Member] \| Measurement Input, Expected Volatility (Peer Group) [Member]
Class Of Warrant Or Right [Line Items]
Warrants and rights outstanding, measurement input	101.00			94.00
Convertible Promissory Note [Member] \| Measurement Input, Expected Life (in Years) [Member]
Class Of Warrant Or Right [Line Items]
Expected life (in years)	4 years 5 months 15 days			5 years